Dedicated to 120 clinical neurologists in training who did not yet complete their residency/ clinical speciality training who wish to boost their knowledge and to get the chance to enable personal contacts among participants and faculty members. Contributions to the optimal organisation of neurological care, neurological services and postgraduate education throughout Europe will be presented.

The Third High-Level Meeting of the United Nations on Non-Communicable Diseases – Time to deliver leaving no one behind and Report on the 68th Session of the WHO Regional Committee for Europe

Health research in Europe needs and inclusive and long term policy to achieve better health and wellbeing of citizens and to create societal and economic value for Europe.

The award was introduced by Dystonia Europe in 2003 and is presented every two years to stimulate research on dystonia, especially by young scientists in Europe.

The Norwegian Brain Council, established in 2007, was one of the first of its kind in Europe. The initiative for it came from key members of the Norwegian Neurological Association, and today the council is seen as a key contributor to the Norwegian health system.

by Anna Sauerbier

Prof. Dafin Muresanu (DF): Dear Prof. Flodmark can you please introduce the European Board of Interventional Neurology – EBNI to the readers of the EAN Pages. Prof. Olof Flodmark (OF): European Board of Neurointervention – EBNI is an independent European Society formed with the aim to support a multidisciplinary approach to neurointerventions by providing guidelines for practice and training and by recognizing individual competence and skills in neurointerventions.

EFNA is focusing attention on young neurology patients during 2018. Their goal is to create a programme that assists young people in becoming advocates for their own disease areas.

The European Parliament Interest Group on Mental health, Well-being and Brain Disorders (with co-hosting MEPs Tomas Zdechovsky and Nessa Childers), EBC, GAMIAN-Europe, the European Psychiatric Association (EPA), EUFAMI, the Expert Platform on Depression, Eurocarers, the European College of Neuropsychopharmacology (ECNP), the UEMS – Sector of Psychiatry and the International Federation for Psychotherapy have launched a joint policy paper on major depression, entitled ‘A sustainable approach to depression: moving from words to actions’, at the European Parliament in Brussels.

The Moroccan Society of Neurology (MSN) was very pleased to organise with the European Academy of Neurology (EAN) the EAN Day on the margins of the Maghrebian Congress of Neurology, held in the beautiful and charming city of Marrakech.

Please find below articles from Czech authors and co-authors
that were published in the European Journal of Neurology   Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III… Continue Reading

Reference Networks: A second opinion - How EU networks share knowledge to save lives

As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers  which session one should not miss at the upcoming congress in Oslo 2019. Please find their answers below!

As 2018 draws to a close, the Social Impact of Pain (SIP) initiative can be proud of its achievements in the past 12 months.

The African Academy of Neurology (AFAN) was created in August 2015 under the aegis of the WFN to be the African regional representative body for all that relates to neurology and allied fields. AFAN collaborates actively with other international organisations; the WFN, EAN, AAN, and MDS amongst others, to achieve the goals of AFAN and its member states. These international-organisations have been invaluable in their support; financially, logistically and by sharing expertise. AFAN is still in its fledgling state and relies greatly on its international partners. With passing years, as we gain experience and become stronger, we hope to reach our place on the international neurological stage as equal partners in the theatre of neurological disease.